Production (Stage)
Atossa Therapeutics, Inc.
ATOS
$0.8317
-$0.0382-4.39%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.72M | -6.35M | -7.23M | -6.05M | -5.88M |
| Total Depreciation and Amortization | 4.00K | 4.00K | 4.00K | 4.00K | 5.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 563.00K | 778.00K | 2.46M | 354.00K | 419.00K |
| Change in Net Operating Assets | 192.00K | -1.49M | 18.00K | 1.16M | 756.00K |
| Cash from Operations | -5.96M | -7.05M | -4.75M | -4.53M | -4.70M |
| Capital Expenditure | -9.00K | 0.00 | -10.00K | -3.00K | -6.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -9.00K | 0.00 | -10.00K | -3.00K | -6.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 3.37M | 0.00 | 100.00K | 204.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 3.37M | 0.00 | 100.00K | 204.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.97M | -3.68M | -4.76M | -4.43M | -4.50M |